entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 22:58:27 - browse：213

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Lasker Awards 2023: Winners in biomedical research

WSS

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Life science postdocs should get big pay hike, NIH panel says

Emergency workers more likely to restrain Black patients: study

Hearing on Medicare drug price negotiation gets unusually heated

Senate HELP committee spars over health care workforce policies

Second xenotransplant done with gene

focus

entertainment

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

As demand for Covid shots wanes, Moderna seeks its next success

Physician assistants need a new name. Here's what it should be

Malaria cases in Florida and Texas: Here’s what you need to know

FDA panel to weigh approval of NurOwn, controversial ALS drug

At least 13 dead in Texas as scorching temps continue

JPM pitch from hospitals? Revenue streams outside of patient care

Sports medicine is finally prioritizing gender equality

CDC's new outbreak response network to include Northeastern

Wikipedia

Nonprofit, backed by Microsoft, to certify AI tools in health care

Ascension's ugly legal battle over care for poor patients in Texas

Gene therapy denied for Afghan refugee whose father aided U.S.

Drug for rare kidney disease narrowly misses mark in clinical trial

Senate HELP committee spars over health care workforce policies

Stories you might have missed in 2023: health, science, medicine

hotspot

knowledge

knowledge

entertainment